GUIOTTO, ADRIANO
 Distribuzione geografica
Continente #
NA - Nord America 12.089
AS - Asia 5.829
EU - Europa 2.896
AF - Africa 954
SA - Sud America 921
Continente sconosciuto - Info sul continente non disponibili 97
OC - Oceania 90
Totale 22.876
Nazione #
US - Stati Uniti d'America 11.544
SG - Singapore 1.884
CN - Cina 1.136
VN - Vietnam 825
IT - Italia 635
BR - Brasile 553
HK - Hong Kong 510
DE - Germania 329
FR - Francia 246
BD - Bangladesh 230
FI - Finlandia 226
IN - India 187
SE - Svezia 166
GB - Regno Unito 143
UA - Ucraina 137
NL - Olanda 124
PL - Polonia 118
CA - Canada 107
IQ - Iraq 96
AR - Argentina 84
RU - Federazione Russa 80
TR - Turchia 76
JP - Giappone 69
PK - Pakistan 67
PH - Filippine 64
ID - Indonesia 55
ZA - Sudafrica 55
MX - Messico 52
SA - Arabia Saudita 50
UZ - Uzbekistan 45
EC - Ecuador 44
IE - Irlanda 44
CI - Costa d'Avorio 43
GR - Grecia 42
CO - Colombia 39
VE - Venezuela 39
EG - Egitto 38
AO - Angola 36
ES - Italia 36
IR - Iran 33
JM - Giamaica 33
TT - Trinidad e Tobago 33
HN - Honduras 32
MA - Marocco 32
TN - Tunisia 32
DZ - Algeria 31
KR - Corea 31
PE - Perù 31
BO - Bolivia 30
CV - Capo Verde 30
JO - Giordania 30
RS - Serbia 30
AT - Austria 29
CR - Costa Rica 29
KE - Kenya 29
RO - Romania 29
SK - Slovacchia (Repubblica Slovacca) 29
TH - Thailandia 29
UY - Uruguay 29
GA - Gabon 28
LV - Lettonia 28
MU - Mauritius 28
MY - Malesia 28
BE - Belgio 27
CH - Svizzera 27
GF - Guiana Francese 27
KG - Kirghizistan 27
LB - Libano 27
NI - Nicaragua 27
BG - Bulgaria 26
DK - Danimarca 26
MG - Madagascar 26
CL - Cile 25
AL - Albania 24
BJ - Benin 24
LY - Libia 24
MR - Mauritania 24
PT - Portogallo 24
YT - Mayotte 24
AM - Armenia 23
EE - Estonia 23
ET - Etiopia 23
GT - Guatemala 23
MD - Moldavia 23
MW - Malawi 23
SI - Slovenia 23
TW - Taiwan 23
UG - Uganda 23
BB - Barbados 22
MN - Mongolia 22
NC - Nuova Caledonia 22
PA - Panama 22
RW - Ruanda 22
TZ - Tanzania 22
AU - Australia 21
AZ - Azerbaigian 21
BY - Bielorussia 21
CD - Congo 21
CZ - Repubblica Ceca 21
DO - Repubblica Dominicana 21
Totale 21.851
Città #
Singapore 1.237
Ashburn 1.110
San Jose 1.104
Fairfield 1.032
Woodbridge 963
Ann Arbor 740
Chandler 637
Houston 618
Jacksonville 543
Hong Kong 464
Wilmington 463
Seattle 391
Cambridge 388
Beijing 259
Santa Clara 234
Council Bluffs 233
Princeton 199
Ho Chi Minh City 192
Dong Ket 184
Boardman 169
Los Angeles 168
Hanoi 150
Des Moines 122
New York 104
Lauterbourg 103
Helsinki 96
San Diego 93
Nanjing 80
Bytom 78
Munich 71
Milan 64
Guangzhou 62
Buffalo 50
Rome 46
São Paulo 46
Tokyo 46
Chicago 44
Medford 44
Roxbury 44
Abidjan 43
Baghdad 42
Padova 39
Tashkent 39
Orem 38
Dallas 37
Da Nang 35
Dublin 35
Frankfurt am Main 31
London 30
Amman 28
Shenyang 28
Haiphong 27
Libreville 27
Nanchang 27
Atlanta 26
Johannesburg 26
Luanda 26
Antananarivo 25
Brooklyn 25
Nairobi 25
Praia 25
Kingston 24
Managua 24
Montevideo 24
Nouakchott 24
Bishkek 23
Kampala 23
The Dalles 23
Kigali 22
Noumea 22
Ulan Bator 22
Lima 21
Montreal 21
Riga 21
Baku 20
Bridgetown 20
Hebei 20
Panama City 20
Shanghai 20
Vienna 20
Yerevan 20
Andorra la Vella 19
Cairo 19
Changsha 19
Cotonou 19
Falls Church 19
Istanbul 19
Jeddah 19
Phoenix 19
Podgorica 19
San José 19
Addis Ababa 18
Belgrade 18
Cayenne 18
Conakry 18
Dakar 18
Lahore 18
Niamey 18
Tianjin 18
Tunis 18
Totale 14.141
Nome #
VALUTAZIONE DELLE ANALISI BIOCHIMICHE IN FARMACIA (POCT): CONFRONTO CON I RISULTATI OTTENUTI SU STRUMENTAZIONI DI LABORATORIO OSPEDALIERE 534
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells 480
1,4,8-Trimethylfuro[2,3-H]quinolin-2(1H)-one, a new furocoumarin bioisoster 475
4-Fluoroproline derivative peptides: Effect on PPII conformation and SH3 affinity 309
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties 291
Synthesis and biological in vitro evaluation of novel PEG-psoralen conjugates 282
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 275
Synthesis and biological evaluation of a new furo[2,3-h]quinolin-2(1H)-one 274
4-Hydroxymethyl-1,6,8-trimethylfuro [2,3-h] quinolin-2 (1H)-one induces mitochondrial dysfunction and apoptosis upon its intracellular oxidation 264
Quality performance of laboratory testing in pharmacies: A collaborative evaluation 262
Photobiological properties of 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one, a new furocoumarin analogue 254
DNA damage induced by 4,6,8,9-Tetramethyl-2H-furo[2,3-h]quinolin-2-one, a new furocoumarin analog: Photochemical mechanisms 251
2,6-Dimethyl-9-methoxy-4H-pyrrolo[3,2,1-ij]quinolin-4-one, a new compound with unusual photosensitizing properties. - 246
Azapsoralens and benzoazapsoralens as new potential photochemo-therapeutic agents 245
A new access to quinazolines from simple anilines 244
New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. 240
Difurocoumarins: Psoralen analogs as photochemotherapeutic agents 239
4-Hydroxymethyl- and 4-methoxymethylfuro[2,3-h]quinolin-2(1H)-ones: Synthesis and Biological Properties 235
Pyrazoloquinazoline tricyclic system as novel scaffold to design new kinase CK2 inhibitors 234
Biological properties of some benzopsoralen derivatives. 233
Psoralen Derivatives as Inhibitors of NF-κB/DNA Interaction: Synthesis, Molecular Modeling, 3D-QSAR, and Biological Evaluation 232
4-Hydroxymethyltetrahydro- and 4-hydroxymethyl-benzopsoralen: synthesis and biological activity. 232
Synthesis of methyl derivatives of 4H-furo[2,3-h]quinolin-4-one and 5H-furo[3,2-g]quinolin-5-one 229
Binding interactions of phospho-Htc peptide to c-Fgr SH2 domain 229
A microwave improvement in the synthesis of the quinazoline scaffold 228
Benzoquinazoline derivatives as new agents affecting DNA processing. 228
On the relationship between body sway and body kinematics durino standing balance in ankylosing spondilytis subjects 228
The Importance of Descriptor-Based Clusterization in QSAR Models Development: Tyrosine Kinases Inhibitors as a Key Study 228
Synthesis of some benzo[c][2,6]naphthyridin-5-ones and new tetracyclic benzofuro[4,5-c]-2,6-naphthyridin-5(6H)-ones 227
Benzoangelicins: New monofunctional DNA photobinding agents 227
Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation 223
Disposition of 1,4,6,8-tetramethyl-furoquinolinone in normal and ascitic tumor bearing mice 223
4,4',5'-Trymethyl-8-azapsoralen, a new photereactive and non-skin-phototoxyc bifunctional bioisoster of psoralen. 223
Synthesis and Biological Activity of Hydroxymethyl and Diethylaminomethylbenzopsoralens. 222
Synthesis and biological properties of some 2H-1-benzopyran [7,8-b][1,4]benzodioxin-2-ones. 222
Synthesis of some methylfurochromones as potential photochemotherapeutic agents. 221
1H-NMR Spectra of variously annulated furocoumarins 220
A novel convenient synthesis of benzoquinazolines 220
Pegylated enzyme entrapped in poly(vinyl alcohol) hydrogel for biocatalytic application 220
Exploring Epidermal Growth Factor Receptor (EGFR) Inhibitor Features: The Role of Fused Dioxygenated Rings on the Quinazoline Scaffold 214
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship. 214
PYRROLOQUINOLINONE METHYLDERIVATIVES, FUROCOUMARIN ANALOGUES - SYNTHESIS AND BIOLOGICAL-ACTIVITY 210
Benzofurocoumarins: new monofunctional DNA-photobinding agents 209
Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression 206
Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity 206
Characterization of isomeric dimethylfuranocoumarins by electron impact ionization and surface and gaseous collision activation mass spectrometry. 205
Quinazoline-based kinase inhibitors: new synthetic approach and biological evaluation. 205
Difurocoumarins, Psoralen Analogs: Synthesis and DNA Photobinding 203
Disposition of 4, 6, 4'-trimethylangelicin in mice maintained in the dark and after uva irradiation. 201
Photophysical properties of halo-derivatives of angelicins 201
Methylpyranochromones and methylbenzodipyranones: new potential photoreagents towards DNA 200
Methylfuroquinolinones: new furocoumarin isosters as potential photoreagents toward DNA. 194
AZAPSORALENS - NEW POTENTIAL PHOTOCHEMOTHERAPEUTIC AGENTS FOR PSORIASIS 194
RNA-protein cross-links induced by sensitization with a pyrroloquinolinone derivative, a furocoumarin analogue. 193
Furochinazoline come potenziali bioisosteri di furocumarine: sintesi e proprieta’ fotobiologiche 193
DNA Damage and Citotoxicity Induced in Mammalian Cells by a Tetramethylfuroquinolinone Derivative 192
13C-NMR Spectra and carbon-proton coupling constants of various annulated furocoumarins 191
Isostero angelicinico con duplice attività antiproliferativa, metodo per la sua preparazione e suoi impieghi in terapia 191
Development of a Novel Furocoumarin Derivative Inhibiting NF-kB Dependent Biological Functions: Design, Synthesis and Biological Effects 189
Synthesis of novel psoralen derivatives as inhibitors of NF-kB dependent biological function 187
Sintesi di nuovi inibitori delle topoisomerasi. 186
4-Anilinoquinazolines endowed with antiangiogenic activity 186
Tetrahydrobenzo-4,6-dimethylangelicin: a new angular furocoumarin forming interstrand photo-cross-links. 185
Microwave-promoted mono-N-alkylation of aromatic amines in water: a new efficient and green method for an old and problematic reaction 184
Effect of 4-fluoro-l-proline on the sh3 binding affinitity 184
6-Arylpyrimidines as novel attractive scaffolds for ATP competitive KSP inhibition 183
Synthesis and evaluation of erlotinib analogues: exploiting ring closure 181
Characterization of isomeric pyranocoumarins by collision-induced tandem mass spectrometry. 181
Targeting tyrosine kinases: anti-proliferative and anti-angiogenic properties of 4-anilinoquinazolines 180
Evaluation of tyrosine conformational restriction in PTK peptide substrates 180
METHYLTRIAZOLOCOUMARINS - NEW FUROCOUMARIN ISOSTERS AS POTENTIAL PHOTOCHEMOTHERAPEUTIC AGENTS 179
Synthesis and antiproliferative activity of furocoumarin isosters. 177
Psoralen derivatives as NF-kB/DNA interaction inhibitors: structural insight into the binding mode 177
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 176
Pyrrolocoumarin derivatives as potential photoreagents toward DNA. 176
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010) 176
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 174
Structure and reactivity of molecular ions of isomeric pyrroloquinolinones and benzoquinolizinones. 174
Photobiological activity of certain pyranocoumarin derivatives: potential agents for the photochemotherapy of psoriasis. 173
Furoquinazolines as furocoumarin analogs: can we improve solubility without impairing biological activity? 171
Effect of 4-S-fluoro-L-proline residue to enhance poly-proline type II helix binding conformation of SH3 binding peptides 169
REGIOSPECIFIC SYNTHESIS OF 1H,5H-BENZO[IJ]QUINOLIZIN-5-ONE AND 3H,5H-BENZO[IJ]QUINOLIZIN-5-ONE DERIVATIVES 167
Biphenyl tricyclic quinazoline compounds 167
Isomerization of 4-Aminobenzofurans to 4-Hydroxyindoles. 166
Synthesis of coumarin compounds as CK2 inhibitors. 165
Synthesis of furo[3,2-g][1,4]benzoxazin-3-ones, new psoralen isosters 163
From single to multi-target kinases inhibitors: using the old-age kinases inhibitors data to face the new-age 162
Synthesis of azapsoralen derivatives. 155
ITMS CAPABILITIES IN ISOMER ANALYSIS .3. CHARACTERIZATION OF METHYL AND DIMETHYL DERIVATIVES OF 8-DESMETHYLSESELINE, POTENTIAL ANTIPROLIFERATIVE AGENTS, BY TANDEM MASS-SPECTROMETRY 153
DNA damage and biological effects induced by photosensitization with new N-1-unsubstituted furo[2,3-h]quinolin-2(1H)-ones 152
FB-Qsar based developement of novel potent Tyrosine-Kinase Inhibitors 150
N-acyl-omega-aminoacid ethanolamides resembling anandamide structure: synthesis and biological evaluation. 150
Synthesis of Benzopsoralenquinone Derivatives 149
New photochemotherapeutic agents: azapsoralens. Mechanism of action. 149
Synthesis of various angular methylfurocoumarins 147
Electrospray mass spectrometry in the differentiation of some isomeric trimethylfurocoumarins 147
SYNTHESIS OF METHYL-DERIVATIVES OF NEW POLYCYCLIC SYSTEMS OF 4H-FURO[3,2-G]PYRROLO[3,2,1-IJ]QUINOLIN-4-ONE, OF 1H,5H-BENZOFURO[5,6,7-IJ]QUINOLIZIN-5-ONE AND 3H,5H-BENZOFURO[5,6,7-IJ]QUINOLIZIN-5-ONE 147
Electron impact mass spectrometry of 7H-furo[ 3,2-g ]quinolin-7-ones and their synthons. 146
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico 145
Biological evaluation of psoralen derivatives as inhibitors of NF-kappa B/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression. 145
Totale 21.024
Categoria #
all - tutte 61.855
article - articoli 46.400
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 980
patent - brevetti 1.702
selected - selezionate 0
volume - volumi 2.613
Totale 113.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.209 0 0 207 82 102 73 76 159 46 17 176 271
2022/20231.322 246 168 12 142 193 241 2 80 138 12 63 25
2023/2024659 40 112 75 52 38 85 32 55 22 25 70 53
2024/20252.537 11 141 140 135 425 51 83 159 238 85 432 637
2025/20269.745 355 808 1.237 1.431 1.014 398 1.294 938 937 631 433 269
2026/20271.259 402 612 245 0 0 0 0 0 0 0 0 0
Totale 22.876